Tesla shares (TSLA)

Key Updates

Tesla shares declined 2.02% to $356.84 since the March 27 report, breaking through the $360 support level and establishing a new YTD low with losses now reaching -20.65%. Three significant developments emerged: positive European sales data showing first growth in over a year, critical upcoming Q1 delivery expectations of 365,645 units (8% YoY growth), and mounting concerns over potential negative free cash flow in 2026 as capital expenditures exceed $20 billion excluding Terafab costs. The stock continues its downward trajectory despite strategic initiatives, as investor focus shifts from automotive fundamentals to the viability of capital-intensive AI and robotaxi investments.

Current Trend

Tesla remains in a pronounced downtrend with YTD losses of -20.65%, extending the decline from -19.26% in the previous report. The stock has broken successive support levels at $380, $370, and now $360, with current price at $356.84 representing the lowest point in 2026. Short-term momentum remains negative across all timeframes: -1.38% (1d), -6.30% (5d), -11.35% (1m), and -19.76% (6m). The breach of $360 support suggests potential further downside toward the $340-350 range unless fundamental catalysts emerge. The upcoming Q1 delivery report represents the next critical inflection point for trend reversal.

Investment Thesis

The investment thesis centers on Tesla's transformation from an automotive manufacturer to an AI and autonomous driving technology company, with Bank of America valuing robotaxi business at $422 billion and FSD software at $313 billion—collectively $735 billion versus $345 billion for the EV division. This thesis requires successful execution across multiple fronts: scaling robotaxi operations from 2 cities to 9 by year-end 2026, growing FSD adoption from 1.1 million to 8.7 million customers by 2030, achieving regulatory approval in China and Europe, and maintaining automotive cash generation ($69.5 billion in 2025 revenue) to fund $20+ billion annual capital expenditures. The core automotive business remains critical as it generates more than double the revenue of all other segments combined and must sustain profitability while funding ambitious AI infrastructure investments including the Terafab semiconductor manufacturing facility.

Thesis Status

The thesis faces increasing stress as execution risks compound. Positive developments include European sales growth of 29% YoY in February 2025 and analyst support with BofA's $488 price target implying 37% upside. However, critical challenges have intensified: projected negative free cash flow of $4.1 billion in 2026 would mark the first negative FCF since 2018, the upcoming Q1 delivery report carries heightened importance as automotive revenue must fund trillion-dollar ambitions, and only 1.1 million of 8.9 million vehicles sold have FSD subscriptions—requiring substantial acceleration to reach 2030 targets. The 23% stock decline over three months reflects market skepticism about capital allocation and timeline to profitability for AI ventures. The thesis remains intact but execution timelines are compressing while capital requirements escalate.

Key Drivers

Immediate: The Q1 delivery report expected to show 365,645 units (8% YoY growth) represents the most critical near-term catalyst, as automotive cash generation must sustain ambitious capital programs. Near-term: Terafab Project launch within 7 days will clarify semiconductor manufacturing strategy and capital requirements, with UBS estimating $30 billion initial investment and potentially $300 billion for full capacity. Robotaxi expansion from 2 to 9 cities in H1 2026 will provide operational validation. Medium-term: FSD regulatory approval in Europe expected summer 2025 via Netherlands entry point could unlock significant market expansion. AI5 chip volume production targeted for 2027 will determine in-house semiconductor capability. Strategic: Free cash flow trajectory in 2026 will validate whether automotive profitability can sustain $20+ billion annual capex while funding robotaxi scaling and Terafab development.

Technical Analysis

Tesla has established a clear downtrend channel with successive support failures at $380, $370, and $360. Current price of $356.84 represents a new YTD low and tests the psychological $350 level. The 6-month decline of -19.76% and YTD loss of -20.65% indicate sustained selling pressure without meaningful bounces. Near-term resistance sits at $370 (previous support turned resistance), with stronger resistance at $390-400 range. Downside support targets $340-350 zone, with potential extension to $320 if delivery report disappoints. The 5-day decline of -6.30% suggests accelerating downward momentum. Volume patterns indicate institutional distribution rather than capitulation selling. A decisive break above $380 with strong volume would be required to signal trend reversal, while failure to hold $350 could trigger accelerated selling toward $300-320 range.

Bull Case

• Robotaxi valuation upside: Bank of America assigns $422 billion value to robotaxi business with potential 50% market share and Morgan Stanley forecasting 5 million robotaxis by 2035, representing transformational revenue opportunity beyond automotive.
• Autonomous technology leadership: Camera-only approach valued at $735 billion combined for robotaxi and FSD provides cost advantage versus competitors' multi-sensor systems, with BofA projecting $1.58 per mile versus $3.41 for traditional ride-sharing.
• European market recovery: First sales growth in over a year with 29% YoY increase in February 2025 EU registrations demonstrates pricing strategy effectiveness and potential demand stabilization in key market.
• Vertical integration strategy: Terafab semiconductor manufacturing facility addresses chip supply constraints as current partners cannot meet AI demand, with AI5 chip targeting 2027 volume production for competitive advantage.
• Diversified value drivers: Optimus robot valued over $30 billion and energy business at $90 billion provide additional growth vectors beyond automotive and robotaxi, reducing single-business dependency.

Bear Case

• Free cash flow turning negative: Projected -$4.1 billion FCF in 2026 would mark first negative result since 2018, with $20+ billion capex excluding Terafab potentially reaching trillion-dollar requirements over time, straining balance sheet despite $44 billion cash position.
• FSD adoption shortfall: Only 1.1 million of 8.9 million vehicles have FSD subscriptions, requiring acceleration to 8.7 million by 2030 for BofA thesis, with regulatory approval still pending in China and Europe representing significant execution risk.
• Automotive revenue dependence: Core automotive generated $69.5 billion revenue—more than double rest of company, creating pressure to maintain delivery growth while investors discount this business, with Q1 expectation of only 8% YoY growth showing deceleration.
• Capital intensity escalation: Terafab estimated at $30 billion initially and potentially $300 billion for full capacity, layered on top of $20 billion annual capex for AI and robotaxi, creates unprecedented capital requirements with uncertain return timelines.
• Market skepticism on AI investments: Stock declined 23% over three months and 13% YTD through early March despite robotaxi announcements, indicating investor concern about capital allocation and profitability timeline, with rotation out of tech stocks pressuring valuation multiple compression.